Ph I/II Study of E7777 Prior to CAR-T for R/R LBCL

NCT04855253 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

SUSPENDED

Status

30

Enrollment

OTHER

Sponsor class

Stopped Accrual met

Conditions

DLBCL
Diffuse Large B Cell Lymphoma
High-grade B-cell Lymphoma
DLBCL Arising From Follicular Lymphoma

Interventions

DRUG: E7777
DRUG: Fludarabine
DRUG: Cyclophosphamide
DRUG: Tisagenlecleucel
DRUG: Axicabtagene Ciloleucel
DRUG: Lisocabtagene Maraleucel Intravenous Suspension

Sponsor

Masonic Cancer Center, University of Minnesota